Literature DB >> 10874268

Is informed consent to clinical trials an "upside selective" process in acute coronary syndromes?

A M Kucia1, J D Horowitz.   

Abstract

METHODS: Patient understanding of clinical trial details was assessed on 2 occasions (10 +/- 4 and 24 +/- 3 hours after randomization) in 20 patients enrolled for randomized investigation of pharmacotherapy for unstable angina pectoris or non-Q-wave myocardial infarction in the Platelet IIb/IIIa Antagonist for the Reduction of Acute Coronary Syndrome Events in a Global Organized Network (PARAGON B) and Organization to Assess Strategies in Ischemic Syndromes (OASIS-2) trials.
RESULTS: Initial total score for understanding of 52.0% (+/-15.7%) of maximal values improved to 67.7% (+/-18.3%) at repeat interview (P <.001). The mean initial score for knowledge of potential benefit was 85.0% (+/-33.3%) with no significant improvement at repeat interview. Scores for knowledge of risk improved from 35.0% (+/-36.6%) to 68.2% (+/-41.2%) at repeat interview (P <.005). Significant determinants of poor initial score were female sex, limited education, and presence of pain during the consent process; young age was the only determinant of improvement on repeat assessment.
CONCLUSION: Thus initial understanding of the research protocols for patients with unstable angina pectoris or non-Q-wave acute myocardial infarction was imperfect, with far greater impairment of knowledge of risk than of benefit.

Entities:  

Keywords:  Biomedical and Behavioral Research; Empirical Approach

Mesh:

Substances:

Year:  2000        PMID: 10874268     DOI: 10.1067/mhj.2000.106625

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  10 in total

1.  Is informed consent possible in acute myocardial infarction?

Authors:  B A Foëx
Journal:  Heart       Date:  2004-11       Impact factor: 5.994

2.  Patients' experiences of intervention trials on the treatment of myocardial infarction: is it time to adjust the informed consent procedure to the patient's capacity?

Authors:  A Agård; G Hermerén; J Herlitz
Journal:  Heart       Date:  2001-12       Impact factor: 5.994

3.  Premature stopping and informed consent in AMI trials.

Authors:  J Hilden; A Gammelgaard
Journal:  J Med Ethics       Date:  2002-06       Impact factor: 2.903

4.  "Teach-to-Goal" to Better Assess Informed Consent Comprehension among Incarcerated Clinical Research Participants.

Authors:  Cyrus Ahalt; Rebecca Sudore; Marielle Bolano; Lia Metzger; Anna M Darby; Brie Williams
Journal:  AMA J Ethics       Date:  2017-09-01

5.  Informing the uninformed: optimizing the consent message using a fractional factorial design.

Authors:  Alan R Tait; Terri Voepel-Lewis; Vijayan N Nair; Naveen N Narisetty; Angela Fagerlin
Journal:  JAMA Pediatr       Date:  2013-07       Impact factor: 16.193

6.  Patients' perceptions of informed consent in acute myocardial infarction research: a questionnaire based survey of the consent process in the DANAMI-2 trial.

Authors:  A Gammelgaard; O S Mortensen; P Rossel
Journal:  Heart       Date:  2004-10       Impact factor: 5.994

7.  Repeated assessments of informed consent comprehension among HIV-infected participants of a three-year clinical trial in Botswana.

Authors:  Lelia H Chaisson; Nancy E Kass; Bafanana Chengeta; Unami Mathebula; Taraz Samandari
Journal:  PLoS One       Date:  2011-10-27       Impact factor: 3.240

8.  Placebo-controlled clinical trials: how trial documents justify the use of randomisation and placebo.

Authors:  Tapani Keränen; Arja Halkoaho; Emmi Itkonen; Anna-Maija Pietilä
Journal:  BMC Med Ethics       Date:  2015-01-11       Impact factor: 2.652

Review 9.  Medical research in emergency research in the European Union member states: tensions between theory and practice.

Authors:  Erwin J O Kompanje; Andrew I R Maas; David K Menon; Jozef Kesecioglu
Journal:  Intensive Care Med       Date:  2014-02-26       Impact factor: 17.440

10.  Recruiting for epigenetic research: facilitating the informed consent process.

Authors:  Nancy Jallo; Debra E Lyon; Patricia Anne Kinser; Debra Lynch Kelly; Victoria Menzies; Colleen Jackson-Cook
Journal:  Nurs Res Pract       Date:  2013-06-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.